This is the most important question and the answer is not simple
Even before its approval, a 2009 joint consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes recommended the use of GLP-1 receptor agonists in patients where minimizing hypoglycemia or promoting weight loss was an important consideration [33]
August 2025 : As of August 1, 2025, 2,190 Ozempic/GLP-1 lawsuit cases were pending in the Ozempic/GLP-1 MDL proceeding
These are early signals, but ones that deserve careful attention and have clinical implications for how combination therapy of metformin and GLP-RA is approached in routine practice
By contrast, clinics like Henry Meds and MEDVi include labs or offer newer medications such as semaglutide and tirzepatide at lower monthly costs, making Invigor feel expensive for the value
You start by taking our free assessment quiz, which gathers information about your current medication use, your health history, and your weight loss goals